Effective 4/10/2018

The Centers for Medicare & Medicaid Services (CMS) has released a change request that informs contractors that effective for claims with dates of service …

Effective 3/16/2018

The Centers for Medicare & Medicaid Services (CMS) covers diagnostic laboratory tests using Next Generation Sequencing (NGS) when performed in a Clinical Laboratory …

Effective 2/15/2018

Effective for claims with dates of service on or after February 15, 2018, CMS advised that coverage of Implantable Cardiac Defibrillators (ICDs) is no longer contingent …

Effective 5/25/2017

Effective for services performed on or after May 25, 2017, The Centers for Medicare & Medicaid Services (CMS) will cover supervised exercise therapy (SET) for beneficiaries with intermittent claudication …

Effective 4/3/2017

The Centers for Medicare and Medicaid Services (CMS) has amended its previous National Coverage Determination (NCD) for HBO therapy by removing Section C from the NCD …

Effective 8/29/2017

The Centers for Medicare & Medicaid Services (CMS) has signaled its intent to cover leadless pacemakers through Coverage with Evidence Development (CED). Medicare covers leadless pacemakers …

Effective 12/7/2016

The Centers for Medicare & Medicaid Services (CMS) has determined that percutaneous image-guided lumbar decompression (PILD) for lumbar spinal stenosis (LSS) is not reasonable and necessary …

Effective 9/28/2016

Medicare will cover a screening test for hepatitis B (HBV) infection in nonpregnant adolescents and adults without symptoms of the infection who are determined by their primary …

Effective 8/30/2016

The Centers for Medicare & Medicaid Services (CMS) is not issuing a National Coverage Determination (NCD) at this time on gender reassignment surgery for Medicare beneficiaries with gender …

Effective 2/28/2016

Medicare covers percutaneous left atrial appendage closure (LAAC) for non-valvular atrial fibrillation when the device has received FDA premarket approval …

Effective 1/27/2016

Medicare is expanding national coverage for allogeneic hematopoietic stem cell transplantation (HSCT) for three separate medical conditions …

Effective 7/09/2015

Effective for services performed on or after 7/9/2015, Medicare will cover testing for Human Papillomavirus (HPV) once every 5 years for beneficiaries without symptoms …

Effective 4/13/2015

Effective for services performed on or after 4/13/2015, Medicare will cover annual voluntary HIV screening for beneficiaries age 15 to 65 and for beneficiaries younger …